Skip to main content
Cancer Cell International logoLink to Cancer Cell International
. 2022 Dec 7;22:384. doi: 10.1186/s12935-022-02802-9

Correction: FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma

Liang Wang 1,, Caiyan Shi 2, Jie Yu 3, Yilin Xu 4,
PMCID: PMC9730665  PMID: 36476228

Correction: Cancer Cell International (2022) 22: 47 https://doi.org/10.1186/s12935-021-02372-2

In this article [1], the affiliation details of the authors Dr. Caiyan Shi and Yilin Xu was transposed. It has been corrected with this erratum.

The correct affiliations are given below:

Caiyan Shi: The Department of Medical Oncology, Hainan West Central Hospital, Danzhou, 571700, Hainan, China.

Yilin Xu: Department of Nephrology, Affiliated Huaian Hospital of Xuzhou Medical University, Huaian, 223001, Jiangsu, China.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Liang Wang and Caiyan Shi contributed equally to this work

Contributor Information

Liang Wang, Email: wangliang@hainancancerhospital.cn.

Yilin Xu, Email: 13852347154@qq.com.

Reference

  • 1.Wang L, Shi C, Yu J, Xu Y. FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma. Cancer Cell Int. 2022;22(1):1–13. doi: 10.1186/s12935-021-02372-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Cell International are provided here courtesy of BMC

RESOURCES